Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 21 Feb 2024 Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development PLOS Neglected Tropical Diseases
Scientific articles 20 Feb 2024 A sample-centric and knowledge-driven computational framework for natural products drug discovery ACS Central Science
Scientific articles 31 Jan 2024 Onchocerciasis drug discovery: In vitro evaluation of FDA-approved drugs against onchocerca gutturosa in Gambia Pharmaceutics
Scientific articles 30 Jan 2024 Late-stage diversification of pyrazoles as antileishmanial agents ChemMedChem
Scientific articles 24 Jan 2024 Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains Antiviral Research
Scientific articles 23 Jan 2024 Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens iScience
Scientific articles 21 Jan 2024 Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa Clinical Pharmacology and Therapeutics
Scientific articles 10 Jan 2024 Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial The Lancet Infectious Diseases
Scientific articles 25 Dec 2023 Madurastatins with imidazolidinone rings: Natural products or side-reaction products from extraction solvents? International Journal of Molecular Sciences
Scientific articles 15 Dec 2023 Facing the escalating burden of dengue: Challenges and perspectives PLOS Global Public Health
Scientific articles 13 Dec 2023 DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1 Science Translational Medicine
Scientific articles 13 Dec 2023 Short-course combination treatment for experimental chronic Chagas disease Science Translational Medicine
Scientific articles 5 Dec 2023 Estimating the proportion of relapse following treatment of visceral leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review Lancet Regional Health Southeast Asia
Scientific articles 27 Nov 2023 A simulation-based method to inform serosurvey designs for estimating the force of infection using existing blood samples PLOS Computational Biology
Scientific articles 21 Nov 2023 Clinical use of molecular methods for Trypanosoma cruzi infection in endemic and non-endemic countries: Benefits, limitations and challenges Frontiers in Parasitology
Scientific articles 21 Nov 2023 Safety and efficacy of paromomycin/ miltefosine/ liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study PLOS Neglected Tropical Diseases